The well-being and safety of the users of any item, particularly drugs is the focus of any manufacturing organization. The process of developing medicine or drugs is rigorous and must pass through numerous phases or stages before it is deemed fit and safe for use. It has to go through the required regulations, where all critical tests and research necessary are conducted and approved by relevant bodies or authorized institutions.
Research, analysis, and development of a new item take more than 12 years for its approval and acceptance as fit and safe for use. Before drugs are given to the first patients, it should have been tested through all the process cycle to avoid risking or endangering the life of the people. Though dozens of items and drugs introduced in the market every year, many are not approved for use (Li et al., 2013).
Delegate your assignment to our experts and they will do the rest.
The safety and analysis of new items, especially pharmaceuticals, should be done following the international health standards. Testing and researching for the fitness of the drug are done during the development process. At the development process, all tests and research are carried out for its effectiveness and safety. They are having an understanding of the illness process and procedures that new medicines and treatments are manufactured. Researchers look for compounds from fungi, plants, aquatics animals, and natural compounds that are used to test if the drug is fit ad safe for use (Li et al., 2013). It is not justifiable with the modern research and guidelines to test and examine the drug or any item when it is the market. The World Health Organization (WHO) has stipulated all the processes, tests, and research when coming up with different drugs in the pharmaceutical market.
In conclusion, new items, especially drug introduction in the market, are sensitive and therefore, should follow due process. Some drugs are tested during the course of development while others after. However, there are safety measures put in place to ensure their safety and usefulness for those using (Li et al., 2013). All safety measures are assessed before the drug administration to the patients.
Reference
Li, Q. C., Qiu, F., McWilliams, W., Pape, C., Song, J. J., Swanek, F., & O’Connor, D. (2013). Best practices for drug substance stress and stability studies during early stage development. Part III—how to make science-and risk-based stability testing decisions for drug substance batchesproduced after manufacturing process Changes. Journal of Pharmaceutical Innovation , 8 (4), 229-239.
